A Randomized Phase III Study of Sublobar Resection versus Stereotactic Ablative Radiotherapy in High Risk Patients with Stage I Non-Small Cell Lung Cancer

PIs: Hiran C. Fernando, M.D.

           Thoracic/General Surgery, Boston Medical Center


          Robert Timmerman, M.D. 

          Radiation Oncology, UT Southwestern Medical Center



The Joint Lung Cancer Trialist's Coalition would like to acknowledge support from Varian Medical Systems, Accuray and Elekta. The program is administered by the Department of Radiation Oncology at UT Southwestern Medical Center.